{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "Cholinesterase", "Docking study", "Dual binding", "Morris water maze", "Tacrine-1,2,3-triazole"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27863370", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "17"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "11", "Day": "08"}], "ELocationID": ["10.1016/j.ejmech.2016.11.008", "S0223-5234(16)30946-1"], "Language": ["eng"], "Journal": {"ISSN": "1768-3254", "JournalIssue": {"Volume": "125", "PubDate": {"Year": "2017", "Month": "Jan", "Day": "05"}}, "Title": "European journal of medicinal chemistry", "ISOAbbreviation": "Eur J Med Chem"}, "ArticleTitle": "Novel tacrine-1,2,3-triazole hybrids: In\u00a0vitro, in\u00a0vivo biological evaluation and docking study of cholinesterase inhibitors.", "Pagination": {"StartPage": "1200", "EndPage": "1212", "MedlinePgn": "1200-1212"}, "Abstract": {"AbstractText": ["A new series of tacrine-1,2,3-triazole hybrids were designed, synthesized, and evaluated as potent dual cholinesterase inhibitors. Most of synthesized compounds showed good in\u00a0vitro inhibitory activities toward both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among them, 7-chloro-N-((1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)-1,2,3,4-tetrahydroacridin-9-amine (5l) was found to be the most potent anti-AChE derivative (IC<sub>50</sub>\u00a0=\u00a00.521\u00a0\u03bcM) and N-((1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)-1,2,3,4-tetrahydroacridin-9-amine (5j) demonstrated the best anti-BChE activity (IC<sub>50</sub>\u00a0=\u00a00.055\u00a0\u03bcM). In\u00a0vivo studies of compound 5l in Morris water maze task confirmed memory improvement in scopolamine-induced impairment. Also, molecular modeling and kinetic studies showed that compounds 5l and 5j bound simultaneously to the peripheral anionic site (PAS) and catalytic sites (CS) of the AChE and BChE."], "CopyrightInformation": "Copyright \u00c2\u00a9 2016 Elsevier Masson SAS. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Najafi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimpour-Razkenari", "ForeName": "Elahe", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Science and Research Branch Islamic Azad, Tehran, Iran."}], "LastName": "Asatouri", "ForeName": "Raymond", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Vafadarnejad", "ForeName": "Fahimeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran."}], "LastName": "Moghadam", "ForeName": "Farshad Homayouni", "Initials": "FH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Khanavi", "ForeName": "Mahnaz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: msharifzadeh@tums.ac.ir."}], "LastName": "Sharifzadeh", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: akbarzad@tums.ac.ir."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Eur J Med Chem", "NlmUniqueID": "0420510", "ISSNLinking": "0223-5234"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazoles"}, {"RegistryNumber": "4VX7YNB537", "NameOfSubstance": "Tacrine"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Memory Disorders"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["cytology", "drug effects", "enzymology"], "DescriptorName": "Neurons"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Tacrine"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Triazoles"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "8", "Day": "10"}, {"Year": "2016", "Month": "11", "Day": "1"}, {"Year": "2016", "Month": "11", "Day": "4"}, {"Year": "2016", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "19", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27863370", "10.1016/j.ejmech.2016.11.008", "S0223-5234(16)30946-1"]}}], "PubmedBookArticle": []}